Cosequin® DS for Dogs
Cosequin® DS is the original researched brand scientifically formulated to support and help maintain the health of pets’ joints and connective tissue. It is also the number-one veterinarian recommended joint health supplement brand▼.
Cosequin is the only glucosamine/chondroitin sulfate supplement that has been shown safe, effective, and bioavailable in peer-reviewed, published, controlled, U.S. veterinary studies, and is manufactured following standards similar to those practiced by the pharmaceutical industry. It is very important to note that the published studies on Cosequin do not apply to other brands.
Click here to download our brochure
Each Chewable Tablet Contains:
† Cosequin contains FCHG49® Glucosamine and TRH122® Sodium Chondroitin Sulfate, Nutramax Laboratories® proprietary veterinary researched specifications.
▲ Reported on a hydrous basis.
■ From Manganese Ascorbate.
▼Source: Surveys conducted in October 2001, March 2004, and February 2007 of small animal veterinarians who recommended oral joint health supplements.
Instructions for use:
The recommended initial administration period is four to six weeks; however, some dogs may respond in a shorter period of time. The number of Cosequin DS chewable tablets may then be reduced to the maintenance level. The chewable tablets may be fed directly or crumbled and mixed with food.
| |
Number of Tablets |
| Dog's Weight |
Initial 4 to 6 Week Administration Period |
Maintenance Level▲ |
| 10-24* lbs |
1 daily (1/2 in the morning &
1/2 in the evening)
*(under 10 lbs, 1/2 daily) |
1/2 daily
(tablets are scored) |
| 25-49 lbs |
2 daily (1 in the morning &
1 in the evening) |
1 daily |
| 50-100 lbs |
3 daily (2 in the morning &
1 in the evening) |
1-2 daily |
| Over 100 lbs |
4 daily (2 in the morning &
2 in the evening) |
2 daily |
▲ Once consistent improvement has been seen, these maintenance levels may be reduced to an every other day administration. The maintenance level can also be used long term on healthy dogs to help support their joints.